Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2001 3
2002 1
2003 2
2004 2
2005 5
2007 3
2008 3
2009 5
2010 3
2011 1
2013 4
2014 9
2015 7
2016 4
2017 5
2018 10
2019 3
2020 6
2021 15
2022 6
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Among authors: kortylewski m. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis.
Zhang B, Zhao D, Chen F, Frankhouser D, Wang H, Pathak KV, Dong L, Torres A, Garcia-Mansfield K, Zhang Y, Hoang DH, Chen MH, Tao S, Cho H, Liang Y, Perrotti D, Branciamore S, Rockne R, Wu X, Ghoda L, Li L, Jin J, Chen J, Yu J, Caligiuri MA, Kuo YH, Boldin M, Su R, Swiderski P, Kortylewski M, Pirrotte P, Nguyen LXT, Marcucci G. Zhang B, et al. Among authors: kortylewski m. Nat Commun. 2023 Sep 1;14(1):5325. doi: 10.1038/s41467-023-41167-z. Nat Commun. 2023. PMID: 37658085 Free PMC article.
The revival of CpG oligonucleotide-based cancer immunotherapies.
Adamus T, Kortylewski M. Adamus T, et al. Among authors: kortylewski m. Contemp Oncol (Pozn). 2018 Mar;22(1A):56-60. doi: 10.5114/wo.2018.73887. Epub 2018 Mar 5. Contemp Oncol (Pozn). 2018. PMID: 29628795 Free PMC article. Review.
Revisiting TLR9 as a target for CLL therapy.
Kortylewski M. Kortylewski M. Blood. 2021 Jun 3;137(22):3006-3008. doi: 10.1182/blood.2020010618. Blood. 2021. PMID: 34081121 Free article. No abstract available.
Call for papers: Exploiting extracellular vesicles as therapeutic agents.
Frederickson RM, Ritter T, Morris K, Kortylewski M, Nasr M, Herzog RW. Frederickson RM, et al. Among authors: kortylewski m. Mol Ther. 2022 Mar 2;30(3):979. doi: 10.1016/j.ymthe.2022.02.007. Epub 2022 Feb 18. Mol Ther. 2022. PMID: 35182469 Free PMC article. No abstract available.
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation.
Esposito CL, Autiero I, Sandomenico A, Li H, Bassal MA, Ibba ML, Wang D, Rinaldi L, Ummarino S, Gaggi G, Borchiellini M, Swiderski P, Ruvo M, Catuogno S, Ebralidze AK, Kortylewski M, de Franciscis V, Di Ruscio A. Esposito CL, et al. Among authors: kortylewski m. Nat Commun. 2023 Jan 6;14(1):99. doi: 10.1038/s41467-022-35222-4. Nat Commun. 2023. PMID: 36609400 Free PMC article.
Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance.
Zhang L, Nguyen LXT, Chen YC, Wu D, Cook GJ, Hoang DH, Brewer CJ, He X, Dong H, Li S, Li M, Zhao D, Qi J, Hua WK, Cai Q, Carnahan E, Chen W, Wu X, Swiderski P, Rockne RC, Kortylewski M, Li L, Zhang B, Marcucci G, Kuo YH. Zhang L, et al. Among authors: kortylewski m. Nat Commun. 2021 Oct 22;12(1):6154. doi: 10.1038/s41467-021-26420-7. Nat Commun. 2021. PMID: 34686664 Free PMC article.
99 results